Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium breve MAK40B22B and Improved Cognitive Function

Research synthesisModerate evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 randomized controlled trials, all 3 reported beneficial effects on cognitive function, with effect sizes ranging from small to large (two small, one large). Studies focused on older adults with mild cognitive impairment or memory complaints. Evidence is preliminary due to the small number of studies.

  • Studied populations: Older adults with mild cognitive impairment or memory complaints

Caveats: Available evidence is overwhelmingly positive but based on only 3 studies, so conclusions are preliminary. Clinical literature is subject to publication bias (null-result studies are less likely to be published or indexed). Additionally, the exact dose and form used were not consistently reported, and effects were observed primarily on specific cognitive subscales rather than global measures.

Generated Jul 12, 2026
4 of 4 papers
Back to top